Nancy J. Linck

82 year

Consumer Services

Health Technology

Profile

Nancy J.
Linck has been Senior Vice President of Intellectual Property & Regulatory Affairs and Chief Compliance Counsel for Guilford Pharmaceuticals, Inc. since February 2004.
She received a BS from the University of California at Berkeley, an MS and a PhD from the University of California in San Diego and a JD from the Western New England College School of Law.

Former positions of Nancy J. Linck

Companies	Position	End
Guilford Pharmaceuticals, Inc. Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury	General Counsel	2005-10-02

See the detail of Nancy J. Linck's experience

Training of Nancy J. Linck

University of California, Berkeley	Undergraduate Degree
University of California San Diego	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies